MDNAF

Medicenna Therapeutics Corp.

Healthcare · Biotechnology

$231.87 sample

+0.56 (+0.24%) 1D

Market cap

$1.48T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-23

Alerts

8

Price$231.87 -0.39% 3M daily closessample

242.61220.84

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Chief Financial Officer
Oct 06INSInsider buy: EVP, Operations
Sep 28INSInsider sell: Director
Sep 23SEC8-K filed: material event
Sep 16INSInsider buy: 10% owner
Sep 08INSInsider buy: Chief Executive Officer
Sep 03INSInsider sell: EVP, Operations
Aug 28INSInsider buy: General Counsel

Sign up to see the real MDNAF record →

Company facts

SEC EDGAR registration

Name: Medicenna Therapeutics Corp.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +46sample, -100 to +100
Reporting currency: USD

Who is positioning in MDNAF

sample

Insiders: 35 insider transactions over 90 days, net selling, $467.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 9 funds hold $8.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$58.6B +19.8% y/y

Q4 2024Q3 2026

Inventory$34.1B +10.8% y/y

Q4 2024Q3 2026

Accounts receivable$26.4B +18.5% y/y

Q4 2024Q3 2026

Total debt$71.2B +16.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.11T +11.1% 3M
Sample peer B: $228.6B +9.5% 3M
Sample peer C: $394.1B +14.9% 3M
Sample peer D: $1.25T +0.0% 3M
Sample peer E: $631.1B -3.1% 3M